Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
Wang, Shengjun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S042000, C514S043000, C514S894000
Reexamination Certificate
active
10441984
ABSTRACT:
The invention is directed to methods of treating, preventing, or inhibiting a Hepatitis C viral infection in a mammal comprising contacting the mammal with an effective amount of a compound of the formula:Wherein substitutions at R1, R2, R3—R12, and Y are set forth in the specification.
REFERENCES:
patent: 3843681 (1974-10-01), Demerson et al.
patent: 3880853 (1975-04-01), Demerson et al.
patent: 3939178 (1976-02-01), Demerson et al.
patent: 3974179 (1976-08-01), Demerson et al.
patent: 4012417 (1977-03-01), Demerson et al.
patent: 4036842 (1977-07-01), Dobson et al.
patent: 4070371 (1978-01-01), Demerson et al.
patent: 4076831 (1978-02-01), Demerson et al.
patent: 4118394 (1978-10-01), Demerson et al.
patent: 4179503 (1979-12-01), Asselin et al.
patent: 4501899 (1985-02-01), Abraham et al.
patent: 4503901 (1985-03-01), Vinogradov et al.
patent: 4515961 (1985-05-01), Demerson et al.
patent: 4520203 (1985-05-01), Abraham et al.
patent: 4544757 (1985-10-01), Demerson et al.
patent: 4585877 (1986-04-01), Demerson et al.
patent: 4670462 (1987-06-01), Katz et al.
patent: 4686213 (1987-08-01), Ferdinandi et al.
patent: 4695623 (1987-09-01), Stabinsky
patent: 4785015 (1988-11-01), McKittrick et al.
patent: 4810699 (1989-03-01), Sabatucci et al.
patent: 4822781 (1989-04-01), Katz et al.
patent: 4822893 (1989-04-01), Failli
patent: 4897471 (1990-01-01), Stabinsky
patent: 4960902 (1990-10-01), Failli
patent: 5071853 (1991-12-01), Bigge et al.
patent: 5128363 (1992-07-01), Failli
patent: 5223517 (1993-06-01), Müller
patent: 5599946 (1997-02-01), Vincenzo et al.
patent: 5633388 (1997-05-01), Diana et al.
patent: 5776967 (1998-07-01), Kreft et al.
patent: 5824699 (1998-10-01), Kreft et al.
patent: 5830905 (1998-11-01), Diana et al.
patent: 5830911 (1998-11-01), Failli et al.
patent: 6066741 (2000-05-01), Vigano et al.
patent: 6110955 (2000-08-01), Nudelman et al.
patent: 6172046 (2001-01-01), Albrecht
patent: 6177440 (2001-01-01), Bach et al.
patent: 6297260 (2001-10-01), Bandarage et al.
patent: 6331638 (2001-12-01), Raghavan et al.
patent: 6365605 (2002-04-01), Lavielle et al.
patent: 6383768 (2002-05-01), De Francesco et al.
patent: 6410583 (2002-06-01), Labelle et al.
patent: 2003/0203926 (2003-10-01), Kois et al.
patent: WO 95/13090 (1995-05-01), None
patent: WO 98/40066 (1998-09-01), None
patent: WO 98/40078 (1998-09-01), None
patent: WO 01/28555 (2001-04-01), None
patent: WO 02/04425 (2002-01-01), None
patent: WO 02/46170 (2002-06-01), None
patent: WO 02/46171 (2002-06-01), None
Latrine et al. “Hepatite Aigue Associee A La Prise D' Etoclolac”, Therapie, vol. 47 (1), 1992 pp. 82-83. (English language translation enclosed).
Trechot et al., “Incidence of hepatitis Induced by Non-Steridal Anti-inflammatory Drugs (NSAID)”, Annals of the Pheumatic Disease, vol. 55 (12) 1996 pp. 936.
Mallat, “Drug-induced Hepitatis: Diagnosis and Treatment”, Gastroenterologic Clinique Et Biologigue, vol. 23 (8-9), 1999, pp. 906-914. (English language translation enclosed).
Hepatology, 1997, vol. 26 (1), pp. 2S-10S.
Purcell,Hepatology1997, vol. 26 (1), pp. 11S-14S.
Bartenschlager,Antiviral Chemistry and Chemotherapy, 1997, vol. 8 (4), pp. 281-301.
Bartenschlager et al.,J. General Virology, 2001, vol. 81, part 7, pp. 1631-1648.
Ferrari et al.,J. Virology, 1999, vol. 73 (2), pp. 1649-1654.
Takamizawa et al.,J. Virology, 1991, vol. 65 (3), pp. 1105-1113.
Courtin,Helv. Chim. Acta, 1983, vol. 66 (1), pp. 68-75.
McKittrick et al.,J. Heterocyclic Chem. 1990, vol. 27 (7), pp. 2151-2163.
Blight et al.,Science, 2000, vol. 290 ( 5498), pp. 1972-1974.
Lohmann et al.,Science, 1999, vol. 285 (5424), pp. 110-113.
Pietschmann et al.,J. Virol, 2001, vol. 75 (3), pp. 1252-1264.
Lohmann et al.,J. Virol. , 2001, vol. 75 (3), pp. 1437-1449.
Humber et al., J. Med. Chem., 1986, vol. 29, pp. 871-874.
Burns Christopher J.
Collett Marc S.
Condon Stephen M.
Ellingboe John W.
Gopalsamy Ariamala
Fitzpatrick ,Cella, Harper & Scinto
ViroPharma Incorporated
Wang Shengjun
Wyeth
LandOfFree
Method for the use of pyranoindole derivatives to treat... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the use of pyranoindole derivatives to treat..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the use of pyranoindole derivatives to treat... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3775607